收稿日期: 2023-10-27
网络出版日期: 2024-04-08
基金资助
河南省自然科学基金项目(222300420489)
Research progress of exosomes in distant metastasis and drug resistance of gastric cancer
Received date: 2023-10-27
Online published: 2024-04-08
胃癌（Gastric cancer）是最常见的肿瘤之一，是全球癌症相关死亡的第四大原因。因早期GC缺乏特异性体征，大多数病例确诊时已经是晚期，常伴有浸润和远处转移。化疗虽是胃癌最常用的疗法，但因耐药性的出现，许多患者在化疗后仍会复发，导致预后不良。肿瘤微环境（tumor micro environment，TME）中的外泌体（exosome，EXOs）可参加细胞间通讯在GC远处转移及耐药中发挥着重要作用。目前GC远处转移及耐药性的详细机制尚不清楚，确定参与胃癌远处转移及耐药性的外泌体引发的机制可以帮助我们为胃癌转移及耐药的防治找到更可靠的治疗手段。本文就外泌体在胃癌远处转移及耐药中的作用机制作一综述，旨在为胃癌的诊治及研究提供帮助。
陈舒 , 张静蕾 , 荣康 , 张楠 , 孙维义 . 外泌体在胃癌远处转移和耐药性中的研究进展[J]. 实用医学杂志, 2024 , 40(6) : 870 -876 . DOI: 10.3969/j.issn.1006-5725.2024.06.024
Gastric cancer （GC） is one of the most common tumors and the fourth leading cause of cancer-related death worldwide.Due to the lack of specific signs in early GC， most cases are diagnosed at an advanced stage， often accompanied by infiltration and distant metastasis. Although chemotherapy is the most commonly used treatment for gastric cancer， due to the emergence of drug resistance， many patients will still relapse after chemotherapy， resulting in poor prognosis.Exosome （EXOs） in the Tumor micro environment （TME） can participate in intercellular communication and play an important role in GC distant metastasis and drug resistance. At present， the detailed mechanism of GC distant metastasis and drug resistance is still unclear. Identifying the exosome-induced mechanism involved in GC distant metastasis and drug resistance can help us find more reliable treatment methods for GC metastasis and drug resistance.This article reviews the mechanism of exosome in GC distant metastasis and drug resistance， in order to provide help for the diagnosis， treatment and research of GC.
Key words： gastric cancer; exosomes; metastasis; drug resistance; chemotherapy
| 1 | XU X， LI Y， WU Y， et al. Increased ATF2 expression predicts poor prognosis and inhibits sorafenib-induced ferroptosis in gastric cancer［J］. Redox Biol， 2023， 59：102564. doi:10.1016/j.redox.2022.102564 |
| 2 | 严健亮， 景蓉蓉， 谢泽宇， 等. 机器学习在胃癌生物标志物挖掘中的应用进展［J］. 实用医学杂志， 2023， 39（6）：783-787. doi:10.3969/j.issn.1006-5725.2023.06.023 |
| 3 | 中国抗癌协会肿瘤营养专业委员会， 中华医学会肠外肠内营养学分会. 胃癌患者的营养治疗专家共识［J］. 肿瘤代谢与营养电子杂志， 2023， 10（2）：208-212. |
| 4 | YANG H， ZOU X， YANG S， et al. Identification of lactylation related model to predict prognostic， tumor infiltrating immunocytes and response of immunotherapy in gastric cancer［J］. Front Immunol， 2023， 14：1149989. doi:10.3389/fimmu.2023.1149989 |
| 5 | WANG X， ZHANG J， CAO G， et al. Emerging roles of circular RNAs in gastric cancer metastasis and drug resistance［J］. J Exp Clin Cancer Res， 2022， 41（1）：218. doi:10.1186/s13046-022-02432-z |
| 6 | OUYANG S， LI H， LOU L， et al. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer［J］. Redox Biol， 2022， 52：102317. doi:10.1016/j.redox.2022.102317 |
| 7 | HAN C， ZHANG C， WANG H， et al. Exosome-mediated communication between tumor cells and tumor-associated macrophages： implications for tumor microenvironment［J］. Oncoimmunology， 2021， 10（1）：1887552. doi:10.1080/2162402x.2021.1887552 |
| 8 | ZHANG C， WEI G， ZHU X， et al. Exosome-Delivered circSTAU2 Inhibits the Progression of Gastric Cancer by Targeting the miR-589/CAPZA1 Axis［J］. Int J Nanomedicine， 2023， 18：127-142. doi:10.2147/ijn.s391872 |
| 9 | 陈倩， 唐秋萍. 循环血浆外泌体及其应用研究进展［J］. 实用医学杂志， 2023， 39（15）：1998-2003. doi:10.3969/j.issn.1006-5725.2023.15.024 |
| 10 | QU X， LIU B， WANG L， et al. Loss of cancer-associated fibroblast-derived exosomal DACT3-AS1 promotes malignant transformation and ferroptosis-mediated oxaliplatin resistance in gastric cancer［J］. Drug Resist Updat， 2023， 68：100936. doi:10.1016/j.drup.2023.100936 |
| 11 | CHEN Y， LIU H， ZOU J， et al. Exosomal circ_0091741 promotes gastric cancer cell autophagy and chemoresistance via the miR-330-3p/TRIM14/Dvl2/Wnt/β-catenin axis［J］. Hum Cell， 2023， 36（1）：258-275. doi:10.1007/s13577-022-00790-6 |
| 12 | KIMURA Y， OHZAWA H， MIYATO H， et al. Intraperitoneal transfer of microRNA-29b-containing small extracellular vesicles can suppress peritoneal metastases of gastric cancer［J］. Cancer Sci， 2023. doi:10.1111/cas.15793 |
| 13 | QIU S， XIE L， LU C， et al. Gastric cancer-derived exosomal miR-519a-3p promotes liver metastasis by inducing intrahepatic M2-like macrophage-mediated angiogenesis［J］. J Exp Clin Cancer Res， 2022， 41（1）：296. doi:10.1186/s13046-022-02499-8 |
| 14 | JOHNSTONE R M， ADAM M， HAMMOND J R， et al. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles （exosomes）［J］. J Biol Chem， 1987， 262（19）：9412-9420. doi:10.1016/s0021-9258(18)48095-7 |
| 15 | SADEGHI S， TEHRANI F R， TAHMASEBI S， et al. Exosome engineering in cell therapy and drug delivery［J］. Inflammopharmacology， 2023， 31（1）：145-169. doi:10.1007/s10787-022-01115-7 |
| 16 | PARK M， KIM D， KO S， et al. Breast Cancer Metastasis： Mechanisms and Therapeutic Implications［J］. Int J Mol Sci， 2022， 23（12）：6806. doi:10.3390/ijms23126806 |
| 17 | HU Y， QI C， LIU X， et al. Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer［J］. Cancer Lett， 2019， 457：142-150. doi:10.1016/j.canlet.2019.04.034 |
| 18 | ZHU M， ZHANG N， HE S， et al. Exosomal miR-106a derived from gastric cancer promotes peritoneal metastasis via direct regulation of Smad7［J］. Cell Cycle， 2020， 19（10）：1200-1221. doi:10.1080/15384101.2020.1749467 |
| 19 | ZHU M， ZHANG N， MA J， et al. Integration of exosomal miR-106a and mesothelial cells facilitates gastric cancer peritoneal dissemination［J］. Cell Signal， 2022， 91：110230. doi:10.1016/j.cellsig.2021.110230 |
| 20 | ZHU A K， SHAN Y Q， ZHANG J， et al. Exosomal NNMT from peritoneum lavage fluid promotes peritoneal metastasis in gastric cancer［J］. Kaohsiung J Med Sci， 2021， 37（4）：305-313. doi:10.1002/kjm2.12334 |
| 21 | YANG J， ZHANG X， CAO J， et al. Circular RNA UBE2Q2 promotes malignant progression of gastric cancer by regulating signal transducer and activator of transcription 3-mediated autophagy and glycolysis［J］. Cell Death Dis， 2021， 12（10）：910. doi:10.1038/s41419-021-04216-3 |
| 22 | GU J， CHU X， HUO Y， et al. Gastric cancer-derived exosomes facilitate pulmonary metastasis by activating ERK-mediated immunosuppressive macrophage polarization［J］. J Cell Biochem， 2023， 124（4）：557-572. doi:10.1002/jcb.30390 |
| 23 | WU S， TANG C， ZHANG Q W， et al. Overexpression of RAB31 in gastric cancer is associated with released exosomes and increased tumor cell invasion and metastasis［J］. Cancer Med， 2023， 12（12）：13497-13510. doi:10.1002/cam4.6007 |
| 24 | WANG Q， ZHANG C， CAO S， et al. Tumor-derived exosomes orchestrate the microRNA-128-3p/ELF4/CDX2 axis to facilitate the growth and metastasis of gastric cancer via delivery of LINC01091［J］. Cell Biol Toxicol， 2023， 39（2）：519-536. doi:10.1007/s10565-022-09728-y |
| 25 | ZHANG Z， SUN C， ZHENG Y， et al. circFCHO2 promotes gastric cancer progression by activating the JAK1/STAT3 pathway via sponging miR-194-5p［J］. Cell Cycle， 2022， 21（20）：2145-2164. doi:10.1080/15384101.2022.2087280 |
| 26 | WANG Y， LI X， ZHANG T， et al. Neutrophils promote tumor invasion via FAM3C-mediated epithelial-to-mesenchymal transition in gastric cancer［J］. Int J Biol Sci， 2023， 19（5）：1352-1368. doi:10.7150/ijbs.79022 |
| 27 | SHEN X， KONG S， MA S， et al. Hsa_circ_0000437 promotes pathogenesis of gastric cancer and lymph node metastasis［J］. Oncogene， 2022， 41（42）：4724-4735. doi:10.1038/s41388-022-02449-w |
| 28 | WANG M， YU W， CAO X， et al. Exosomal CD44 Transmits Lymph Node Metastatic Capacity Between Gastric Cancer Cells via YAP-CPT1A-Mediated FAO Reprogramming［J］. Front Oncol， 2022， 12：860175. doi:10.3389/fonc.2022.860175 |
| 29 | DUAN C， YU M， XU J， et al. Overcoming Cancer Multi-drug Resistance （MDR）： Reasons， mechanisms， nanotherapeutic solutions， and challenges［J］. Biomed Pharmacother， 2023， 162：114643. doi:10.1016/j.biopha.2023.114643 |
| 30 | CAO S， FU B， CAI J， et al. Linc00852 from cisplatin-resistant gastric cancer cell-derived exosomes regulates COMMD7 to promote cisplatin resistance of recipient cells through microRNA-514a-5p［J］. Cell Biol Toxicol， 2023， 39（2）：483-496. doi:10.1007/s10565-021-09685-y |
| 31 | WANG J， XIANG Y， FAN M， et al. The Ubiquitin-Proteasome System in Tumor Metabolism［J］. Cancers （Basel）， 2023， 15（8）：2385. doi:10.3390/cancers15082385 |
| 32 | JING X， XIE M， DING K， et al. Exosome-transmitted miR-769-5p confers cisplatin resistance and progression in gastric cancer by targeting CASP9 and promoting the ubiquitination degradation of p53［J］. Clin Transl Med， 2022， 12（5）：e780. doi:10.1002/ctm2.780 |
| 33 | XIN L， ZHOU L Q， LIU C， et al. Transfer of LncRNA CRNDE in TAM-derived exosomes is linked with cisplatin resistance in gastric cancer［J］. EMBO Rep， 2021， 22（12）：e52124. doi:10.15252/embr.202052124 |
| 34 | ZHANG H， DENG T， LIU R， et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer［J］. Mol Cancer， 2020， 19（1）：43. doi:10.1186/s12943-020-01168-8 |
| 35 | ABADI A J， ZARRABI A， HASHEMI F， et al. The role of SOX family transcription factors in gastric cancer［J］. Int J Biol Macromol， 2021， 180：608-624. doi:10.1016/j.ijbiomac.2021.02.202 |
| 36 | LIANG Q， CHU F， ZHANG L， et al. circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition［J］. Gut Liver， 2023， 17（3）：389-403. doi:10.5009/gnl210195 |
| 37 | ZHONG Y， WANG D， DING Y， et al. Circular RNA circ_0032821 contributes to oxaliplatin （OXA） resistance of gastric cancer cells by regulating SOX9 via miR-515-5p［J］. Biotechnol Lett， 2021， 43（2）：339-351. doi:10.1007/s10529-020-03036-3 |
| 38 | SHAH D， AJAZUDDIN， BHATTACHARYA S. Role of natural P-gp inhibitor in the effective delivery for chemotherapeutic agents［J］. J Cancer Res Clin Oncol， 2023， 149（1）：367-391. doi:10.1007/s00432-022-04387-2 |
| 39 | SCHIRIZZI A， CONTINO M， CARRIERI L， et al. The multiple combination of Paclitaxel， Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines［J］. Front Oncol， 2023， 13：1129832. doi:10.3389/fonc.2023.1129832 |
| 40 | JIANG L， ZHANG Y， GUO L， et al. Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway［J］. BMC Cancer， 2021， 21（1）：1290. doi:10.1186/s12885-021-09020-y |
| 41 | YANG C， MAI Z， LIU C， et al. Natural Products in Preventing Tumor Drug Resistance and Related Signaling Pathways［J］. Molecules， 2022， 27（11）：3513. doi:10.3390/molecules27113513 |
| 42 | ZHAO Z X， ZHANG Y Q， SUN H， et al. Calcipotriol abrogates cancer-associated fibroblast-derived IL-8-mediated oxaliplatin resistance in gastric cancer cells via blocking PI3K/Akt signaling［J］. Acta Pharmacol Sin， 2023， 44（1）：178-188. doi:10.1038/s41401-022-00927-1 |
| 43 | GUAN W L， HE Y， XU R H. Gastric cancer treatment： recent progress and future perspectives［J］. J Hematol Oncol， 2023， 16（1）：57. doi:10.1186/s13045-023-01451-3 |
/
| 〈 |
|
〉 |